Publication:
New spectrophotometric and spectrofluorimetric methods for the determination of angiotensin II receptor antagonists in tablets and plasma

dc.contributor.authorTekkeli, S. E. Kepekci
dc.contributor.authorOnal, A.
dc.contributor.institutionauthorTEKKELİ, ŞERİFE EVRİM
dc.date.accessioned2019-10-05T14:20:13Z
dc.date.available2019-10-05T14:20:13Z
dc.date.issued2013-06-01
dc.description.abstractSpectrophotometric and spectrofluorimetric methods for the determination of five Angiotensin II type 1 receptor antagonists in tablets and plasma have been developed and optimized. The spectrophotometric method involves the addition of a measured excess of bromate-bromide in HCl medium and subsequent estimation of the residual bromine by reacting with a fixed amount of methyl orange. The spectrofluorimetric method depends on the oxidation of the drugs with cerium(IV) and subsequent monitoring of the fluorescence of the induced cerium(III) at 365 nm with excitation at 255 nm. Both of the proposed methods were successfully applied to the determination of the investigated drugs in their pure forms and pharmaceutical preparations. Besides, the spectrofluorimetric method was applied to the determination of irbesartan and telmisartan in biological fluids with good accuracy and precision.
dc.description.sponsorshipİstanbul Üniversitesi
dc.identifier10.1007/s00508-014-0650-1
dc.identifier.citationTekkeli S. E. K. , Onal A., -New spectrophotometric and spectrofluorimetric methods for the determination of angiotensin II receptor antagonists in tablets and plasma-, JOURNAL OF ANALYTICAL CHEMISTRY, cilt.68, ss.501-509, 2013
dc.identifier.doi10.1134/s1061934813060087
dc.identifier.scopus84878688557
dc.identifier.urihttps://hdl.handle.net/20.500.12645/3591
dc.identifier.wosWOS:000319473100006
dc.language.isoen
dc.titleNew spectrophotometric and spectrofluorimetric methods for the determination of angiotensin II receptor antagonists in tablets and plasma
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameWiener Klinische Wochenschrift
local.avesis.id574921a5-5c17-4693-96ad-5a3c8a186184
local.avesis.response3461
local.publication.isinternational1
relation.isAuthorOfPublication837d5047-762e-43db-b252-9f3d1399378f
relation.isAuthorOfPublication.latestForDiscovery837d5047-762e-43db-b252-9f3d1399378f
Files